BioSyntech, Inc.
BSYI
$0.00
$0.000.00%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Revenue | 176.60K | 180.00K | 70.10K | 35.10K | 164.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 176.60K | 180.00K | 70.10K | 35.10K | 164.10K |
| Cost of Revenue | 61.40K | 61.80K | 26.30K | 14.30K | 65.40K |
| Gross Profit | 115.30K | 118.30K | 43.90K | 21.00K | 98.70K |
| SG&A Expenses | 3.22M | 3.13M | 2.64M | 2.82M | 3.11M |
| Depreciation & Amortization | 403.30K | 379.30K | 396.30K | 397.10K | 445.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.08M | 6.34M | 6.30M | 7.24M | 8.62M |
| Operating Income | -5.91M | -6.16M | -6.23M | -7.21M | -8.45M |
| Income Before Tax | -11.25M | -11.79M | -11.38M | -11.41M | -11.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.25 | -11.79 | -11.38 | -11.41 | -11.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.25M | -11.79M | -11.38M | -11.41M | -11.38M |
| EBIT | -5.91M | -6.16M | -6.23M | -7.21M | -8.45M |
| EBITDA | -5.65M | -5.91M | -5.96M | -6.91M | -8.13M |
| EPS Basic | -0.11 | -0.12 | -0.12 | -0.12 | -0.12 |
| Normalized Basic EPS | -0.07 | -0.06 | -0.06 | -0.06 | -0.07 |
| EPS Diluted | -0.11 | -0.12 | -0.12 | -0.12 | -0.12 |
| Normalized Diluted EPS | -0.07 | -0.06 | -0.06 | -0.06 | -0.07 |
| Average Basic Shares Outstanding | 408.99M | 398.99M | 389.44M | 383.61M | 382.95M |
| Average Diluted Shares Outstanding | 408.99M | 398.99M | 389.44M | 383.61M | 382.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
